BCRX

Galidesivir (BCX4430)

COVID-19

Phase 1 (Data / Information)

Exp Date

Q4 2020

Amp Volatility Score

Catalyst Info & Data Links

TITLE: Galidesivir (BCX4430) - Phase 1 (Data / Information)

  • ClinicalTrial.gov (NCT03891420): A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19


WHAT IS THE CATALYST EVENT?


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?

  • Q4 2020


PRIOR DATA

PRESS RELEASES

posters and publications

MECHANISM OF ACTION / RATIONALE

  • Galidesivir is an adenosine analogue that has been investigated for use against Zaire Ebolavirus. In animal studies, galidesivir was effective in increasing the survival rates from infections caused by various pathogens, including Ebola, Marburg, Yellow Fever and Zika viruses. In vitro, it displayed broad-spectrum antiviral activity against various negative- and positive-sense RNA viruses, including coronaviruses, filoviruses, and arenaviruses. Phase 1 clinical trials have begun to determine the safety of this drug in humans. Because of its activity against other coronaviruses, it may be studied as a potential therapy for COVID-19 (Learn more - National Library of Medicine)

Updated by HC

#BCRX, #Galidesivir, #BCX4430, #COVID

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

Upcoming September 2020 COVID-...

Check out our AmpCards & #COVID19 catalyst tracker for investible small & mid-cap biopharma companies in the COVID therapeutics and vaccine race. Therapeutic candidate data from $VNDA, $BCRX, & $BSGM ...

BCRX - NIAID Awards BioCryst N...

#BCRX announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded BioCryst a new contract (75N93020C00055) totaling $44 mi...

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon